Richard D. Francis, President and CEO: Teva Pharmaceutical Industries TEVA Sell · Filed 03/05

Trade details

Type: Insider sale
Amount: $13,333,355.52
Shares · price: 412,032 sh · $32.36 a share
Held after: 1,121,382 sh
Stock: Teva Pharmaceutical Industries TEVA
Person: Richard D. FrancisPresident and CEO
Trade date: 26/03/03
Filed: 26/03/05
Days to filing: 2 days

Sold 26.9% of holdings

Share of holding sold: 26.9%

Teva Pharmaceutical Industries trades, last 26 weeks

What else happened in Teva Pharmaceutical Industries around then

Filed or reported within 30 days of the trade day · 02/01~04/02

Richard D. Francis's recent trades

Richard D. FrancisPresident and CEO
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$211.4K
6,153 sh
$211.4K
Filed 06/08
Traded 06/05
Richard D. FrancisPresident and CEO
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$211.4K
6,153 sh
$211.4K
Filed 06/05
Traded 06/05
Richard D. FrancisPresident and CEO
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$634.2K
20,025 sh
$634.2K
Filed 03/09
Traded 03/05
Richard D. FrancisPresident and CEO
Sell10b5-1 planTeva Pharmaceutical Industries
Sell10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$759.3K
23,393 sh
$759.3K
Filed 03/06
Traded 03/04
Richard D. FrancisPresident and CEO
Planned sale10b5-1 planTeva Pharmaceutical Industries
Planned sale10b5-1 plan
Teva Pharmaceutical Industries
TEVA
$634.2K
20,025 sh
$634.2K
Filed 03/05
Traded 03/05

Richard D. Francis, CEO — sold $13.3M of Teva Pharmaceutical Industries TEVA · 26.9% of holdings · 10b5-1 plan | Whalegun